Guangdong VTR Bio-Tech Co., Ltd. (SHE:300381)

Guangdong VTR Bio-Tech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	490.09	467.01	669.16	872.58	272.7	303.1
Trading Asset Securities	238.02	332.13	563.7	688.89	-	-
Cash & Short-Term Investments	728.11	799.13	1,233	1,561	272.7	303.1
Cash Growth	-31.81%	-35.18%	-21.04%	472.59%	-10.03%	39.71%
Accounts Receivable	242.29	232.18	231.91	248.79	565.34	604.6
Other Receivables	6.6	3.7	8.44	5.1	26.07	33.95
Receivables	248.89	235.89	240.35	253.89	591.41	638.54
Inventory	200.14	194.71	195.72	205.37	992.45	1,050
Other Current Assets	54.74	53.75	25.62	21.81	95.38	91.89
Total Current Assets	1,232	1,283	1,695	2,043	1,952	2,083
Property, Plant & Equipment	1,197	1,197	953.5	708.22	1,602	1,610
Long-Term Investments	2.5	2.5	9.89	10.31	20.91	23.55
Goodwill	36.67	36.67	36.67	36.67	396.06	476.89
Other Intangible Assets	340.22	318.89	363.68	338.97	422.56	415.84
Long-Term Deferred Tax Assets	23.54	23.08	19.43	16.48	42.59	24.14
Long-Term Deferred Charges	5.39	5.78	8.18	11.16	14.99	19.43
Other Long-Term Assets	54.41	81.01	9.03	7.79	28.74	19.49
Total Assets	2,891	2,949	3,095	3,172	4,480	4,672
Accounts Payable	92.27	130.12	85.67	68.95	331.62	364.68
Accrued Expenses	8.29	31.28	34.48	35.58	50.27	46.88
Short-Term Debt	35	35	74.35	100	656.9	635.88
Current Portion of Long-Term Debt	0.12	0.12	53.78	0.03	59.28	0.13
Current Portion of Leases	-	-	0.12	0.21	0.43	13.51
Current Income Taxes Payable	2.93	6.39	0.86	3.8	7.04	13.68
Current Unearned Revenue	2.45	1.8	1.91	2.3	8.08	4.58
Other Current Liabilities	37.64	37.9	57.7	37.85	53.43	65.71
Total Current Liabilities	178.69	242.62	308.86	248.7	1,167	1,145
Long-Term Debt	-	-	-	51.32	126.69	119.07
Long-Term Leases	-	-	-	-	0.24	-
Long-Term Unearned Revenue	46.46	46.9	44.44	50	122.36	128.24
Long-Term Deferred Tax Liabilities	4.87	4.87	5.67	6.25	15.59	16.94
Other Long-Term Liabilities	-	-	0.82	-	-	-
Total Liabilities	230.03	294.39	359.79	356.26	1,432	1,409
Common Stock	491.06	491.06	490.08	490.08	490.07	490.06
Additional Paid-In Capital	1,633	1,633	1,618	1,614	1,610	1,642
Retained Earnings	602.44	597.57	595.18	653.73	684.51	837.68
Treasury Stock	-100.11	-100.11	-100.11	-61.05	-	-
Comprehensive Income & Other	-9.18	-9.82	11.04	8.69	8.64	8.67
Total Common Equity	2,617	2,612	2,615	2,706	2,793	2,978
Minority Interest	44.33	42.69	120.62	109.97	255.2	284.83
Shareholders' Equity	2,661	2,654	2,735	2,816	3,048	3,263
Total Liabilities & Equity	2,891	2,949	3,095	3,172	4,480	4,672
Total Debt	35.12	35.12	128.24	151.56	843.53	768.6
Net Cash (Debt)	692.98	764.01	1,105	1,410	-570.83	-465.51
Net Cash Growth	-29.59%	-30.84%	-21.65%	-	-	-
Net Cash Per Share	1.41	1.56	2.25	2.88	-1.16	-0.99
Filing Date Shares Outstanding	491.97	490.88	479.19	483.65	490.07	490.06
Total Common Shares Outstanding	491.97	490.88	479.19	483.65	490.07	490.06
Working Capital	1,053	1,041	1,386	1,794	784.9	937.98
Book Value Per Share	5.32	5.32	5.46	5.59	5.70	6.08
Tangible Book Value	2,240	2,256	2,214	2,330	1,974	2,085
Tangible Book Value Per Share	4.55	4.60	4.62	4.82	4.03	4.26
Buildings	-	-	686.45	683.49	1,177	1,032
Machinery	-	-	539.25	497.2	1,144	1,047
Construction In Progress	-	-	304.27	38.47	204.74	324.37

Updated Oct 22, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.